GSA Capital Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-15,201
| Closed | -$413K | – | 1317 |
|
|
2020
Q1 | $413K | Buy |
+15,201
| New | +$413K | 0.1% | 270 |
|
|
2018
Q1 | – | Sell |
-113,294
| Closed | -$1.58M | – | 1923 |
|
|
2017
Q4 | $1.58M | Buy |
113,294
+55,594
| +96% | +$775K | 0.1% | 329 |
|
|
2017
Q3 | $1.07M | Buy |
+57,700
| New | +$1.07M | 0.07% | 485 |
|
|
2016
Q1 | – | Sell |
-88,251
| Closed | -$1.31M | – | 2017 |
|
|
2015
Q4 | $1.31M | Buy |
88,251
+66,130
| +299% | +$982K | 0.06% | 502 |
|
|
2015
Q3 | $363K | Sell |
22,121
-22,428
| -50% | -$368K | 0.02% | 1272 |
|
|
2015
Q2 | $1.02M | Buy |
+44,549
| New | +$1.02M | 0.04% | 885 |
|
|
2014
Q2 | – | Sell |
-18,114
| Closed | -$211K | – | 2023 |
|
|
2014
Q1 | $211K | Sell |
18,114
-5,400
| -23% | -$62.9K | 0.02% | 1355 |
|
|
2013
Q4 | $416K | Buy |
23,514
+606
| +3% | +$10.7K | 0.03% | 972 |
|
|
2013
Q3 | $330K | Buy |
22,908
+3,015
| +15% | +$43.4K | 0.03% | 1078 |
|
|
2013
Q2 | $300K | Buy |
+19,893
| New | +$300K | 0.04% | 868 |
|